Great...I would have been surprised if others did not see through the charade. This is headed back to where it came from prior to 26th. If approved this will scale $5 effortlessly towards $6. Except for the bigger companies, it is rare to see a new drug applicant that is cash-flow positive, has rich balance sheet, several products in the market, and even buying back stocks. CBRX bought back several million shares in 2010. Monster opportunity here. Will keep this trajectory, can't see the resistance. I guess it was held back because investors couldn't see through the next step and WPI's intentions. Now that those are all settled and WPI is meeting with FDA, expect investors to be buying back positions ahead of the BIG date. Goodnite to all, Hello Senorita!